PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
April 4, 2026

Retraction Note: Simultaneous administration of human acidic and recombinant less acidic follicle-stimulating hormone for ovarian stimulation improves oocyte and embryo quality, and clinical outcome in patients with repeated IVF failures.

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHelmy SelmanAPA PacchiarottiLRL Rinaldi

Discussion

Loading...

Member takes

Overview

Retraction highlights reliability issues with findings on IVF outcomes in patients with repeated failures, indicating data concerns.

Key Points

  • This article aimed to assess the impact of hormone administration on oocyte and embryo quality during IVF treatments.
  • Editorial investigation initiated due to concerns about data similarities with previous articles.
  • Authors were asked to provide original datasets but did not respond despite multiple follow-ups.
  • Reliability of the study findings could not be verified.
  • The journal found substantial data similarities between this and previously published work.
  • As a result, the article was retracted to maintain scientific integrity.

Cite This Study

Selman et al. (2026) studied this question.

synapsesocial.com/papers/69d0ae94659487ece0fa47d3https://doi.org/10.26355/eurrev_202603_37716
View Full Paper
Ask AI
Bookmark
Share